Programmed cell death protein 1

From Food & Medicine Encyclopedia

(Redirected from PD-1)

Programmed cell death protein 1 (also known as PD-1 and CD279 (cluster of differentiation 279)) is a protein that in humans is encoded by the PDCD1 gene. PD-1 is a cell surface receptor that belongs to the immunoglobulin superfamily and is expressed on T cells and pro-B cells. It functions as an immune checkpoint and plays a major role in down regulating the immune system by preventing the activation of T-cells, which in turn reduces autoimmunity and promotes self-tolerance. The inhibitory effect of PD-1 is accomplished through a dual mechanism of promoting apoptosis (programmed cell death) in antigen specific T-cells in lymph nodes while simultaneously reducing apoptosis in regulatory T cells (suppressor T cells).

Function[edit]

PD-1 is an immune checkpoint receptor that is expressed on the surface of activated T cells, B cells, and myeloid cells. The primary function of PD-1 is to limit the activity of T cells in peripheral tissues during an inflammatory response to infection and to limit autoimmunity.

Clinical significance[edit]

PD-1 and its ligands, PD-L1 and PD-L2, are often upregulated in cancer cells and the surrounding microenvironment. This upregulation often leads to the inhibition of T cells that would otherwise recognize and destroy cancer cells. Inhibition of PD-1 or its ligands can restore the cytotoxic activity of T cells against cancer cells, providing the basis for the development of PD-1 inhibitors as cancer therapeutics.

PD-1 inhibitors[edit]

PD-1 inhibitors are a type of immunotherapy that block the interaction between PD-1 and its ligands, thereby enhancing the immune system's anti-tumor response. These drugs have shown significant clinical benefits in the treatment of a variety of cancers, including melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, and head and neck cancers.

See also[edit]

References[edit]

<references />

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.